FineTech Pharmaceutical

Developing Active Pharmaceutical Ingredients

Health Tech & Life Sciences
Acquired by OPKO Health
Acquired Nesher Founded 1990
Website ↗
Total raised
Stage
Acquired
Founded
1990
Headcount
31
HQ
Nesher
Sector
Health Tech & Life Sciences

About

FineTech Pharmaceutical develops and manufactures active pharmaceutical ingredients (APIs) with the goal of bypassing process and polymorph patents. The company also offers analytical method development and patent analysis to help bring clients products to market more quickly. FineTechs APIs include Cabergoline, Latanoprost, Travoprost, Bimatoprost, Nabilone, donepezil hydrochloride, aminolevulinic acid hydrochloride, melatonin, and methylbenzethonium chloride. The company specializes in organic processes, including multi-step synthesis, polymorph development, chromatography, and chiral and prostaglandin chemistry. FineTech operates in six facilities on a single campus. The facility is FDA registered and the company abides by cGMP standards. Founded as FineTech Laboratories Ltd in conjunction with the Technion Israel Institute of Technology, FineTech has been acquired by OPKO Health Inc, which is controlled by Teva Pharmaceutical Industries.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

When was FineTech Pharmaceutical founded and in conjunction with which institution?
FineTech Pharmaceutical was founded in January 1990 as FineTech Laboratories Ltd, in conjunction with the Technion – Israel Institute of Technology.
What is FineTech Pharmaceutical's primary focus in product development?
FineTech Pharmaceutical develops and manufactures active pharmaceutical ingredients (APIs) with the goal of bypassing process and polymorph patents.
Which company acquired FineTech Pharmaceutical and when?
FineTech Pharmaceutical was acquired by OPKO Health Inc. in December 2011 for $27.5 million.
What is the operational status of FineTech Pharmaceutical's facilities?
FineTech Pharmaceutical operates in six facilities on a single campus, which are FDA registered and abide by cGMP standards.
What are some of the active pharmaceutical ingredients (APIs) developed by FineTech Pharmaceutical?
FineTech Pharmaceutical's APIs include Cabergoline, Latanoprost, Travoprost, Bimatoprost, Nabilone, donepezil hydrochloride, aminolevulinic acid hydrochloride, melatonin, and methylbenzethonium chloride.
What specialized organic processes does FineTech Pharmaceutical focus on?
FineTech Pharmaceutical specializes in organic processes such as multi-step synthesis, polymorph development, chromatography, and chiral and prostaglandin chemistry.
How many employees does FineTech Pharmaceutical have?
FineTech Pharmaceutical has 31 employees.
Where is FineTech Pharmaceutical's headquarters located?
FineTech Pharmaceutical's headquarters is located in Nesher, Israel.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

apix-raylaboratoriespharma-companies